What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Whirling Disease in Salmonids: Myxobolus cerebralis Diagnosis and Management in Aquaculture

Introduction

Whirling disease is a debilitating condition affecting salmonid fish species, caused by the myxozoan parasite Myxobolus cerebralis. The disease is characterized by pathological changes in the cartilage and central nervous system of juvenile fish, leading to skeletal deformities, impaired swimming behavior, and high mortality rates in hatchery and wild populations [1, 2]. M. cerebralis is a member of the phylum Cnidaria, class Myxosporea, and exhibits a complex two-host lifecycle that alternates between a salmonid fish host and an aquatic oligochaete worm, Tubifex tubifex [3, 4]. The parasite was first described in Europe in the late 19th century and has since spread globally, causing significant economic losses in aquaculture and threatening wild salmonid stocks [5, 6]. This article provides an exhaustive review of the biology, diagnostic methods, and management strategies for M. cerebralis in aquaculture settings, with a focus on molecular detection and hatchery biosecurity.

Etiology and Lifecycle

Parasite Morphology and Taxonomy

M. cerebralis is a myxozoan parasite that produces two distinct spore types during its lifecycle. The myxospore, which infects the oligochaete host, is lenticular in shape, measuring approximately 10 to 12 micrometers in diameter, and contains two polar capsules with coiled polar filaments [7, 8]. The actinospore, which infects the fish host, is a triactinomyxon type, characterized by three long caudal processes and a central sporoplasm [9]. The triactinomyxon spore is significantly larger, with a total span of 150 to 200 micrometers, and is adapted for suspension in the water column [10].

Two-Host Lifecycle

The lifecycle of M. cerebralis is obligately two-host, requiring both a salmonid fish and T. tubifex for completion [3, 11]. The cycle begins when myxospores, released from decomposing fish carcasses or shed in feces, are ingested by T. tubifex in the sediment [12]. Within the worm's intestinal epithelium, the myxospore germinates, releasing a sporoplasm that undergoes asexual proliferation (schizogony) and subsequent sexual reproduction (sporogony) to produce triactinomyxon actinospores [13]. These actinospores are released into the water column, where they encounter and attach to the skin or gills of a susceptible salmonid host [14]. The sporoplasm penetrates the fish epidermis and migrates via the peripheral nerves to the central nervous system and cartilaginous tissues [15]. Within the fish, the parasite undergoes further development, culminating in the formation of myxospores within the cranial and vertebral cartilage [16]. The myxospores are released upon the death and decomposition of the fish, completing the cycle [17].

graph TD
    A[Myxospores in sediment], >|Ingested by| B[Tubifex tubifex]
    B, >|Asexual and sexual reproduction| C[Triactinomyxon actinospores released into water]
    C, >|Attachment to skin/gills| D[Salmonid fish host]
    D, >|Migration via nerves to cartilage| E[Development of myxospores in cranial/vertebral cartilage]
    E, >|Fish death and decomposition| A

Pathogenesis and Clinical Signs

Host Susceptibility and Age Dependence

Clinical whirling disease is predominantly observed in juvenile salmonids, particularly fry and fingerlings, as the parasite targets developing cartilage [18, 19]. Rainbow trout (Oncorhynchus mykiss) are highly susceptible, whereas brown trout (Salmo trutta) and Atlantic salmon (Salmo salar) exhibit greater resistance [20, 21]. The severity of disease is dose-dependent and correlates with water temperature, with optimal parasite development occurring between 10 and 15 degrees Celsius [22].

Pathological Mechanisms

Upon entry into the fish, the sporoplasm migrates along peripheral nerves to the spinal cord and brain, where it induces a host inflammatory response [23]. The parasite then invades chondrocytes in the cranial and vertebral cartilage, causing chondrolysis, necrosis, and replacement of cartilage with fibrous connective tissue [24]. This destruction of cartilage leads to skeletal deformities, including spinal curvature (scoliosis and lordosis) and cranial deformities [25]. The characteristic whirling behavior results from compression of the brainstem and spinal cord due to inflammation and granuloma formation [26]. In severe cases, the tail may become darkened due to melanophore aggregation, a sign of sympathetic nerve dysfunction [27].

Clinical Presentation

Affected fish exhibit erratic, corkscrew swimming motions, often spinning rapidly in place (whirling) [28]. Other signs include a blackened tail, exophthalmia, jaw deformities, and reduced feeding activity [29]. Mortality rates can exceed 80 percent in heavily infected hatchery populations, with survivors often suffering permanent deformities that impair foraging and predator avoidance [30].

Diagnostic Approaches

Microscopic Examination

Traditional diagnosis relies on the detection of M. cerebralis myxospores in cartilage tissue. The head of a suspect fish is bisected sagittally, and the cranial cartilage is removed, compressed between glass slides, and examined under a compound microscope at 200x to 400x magnification [31]. Myxospores appear as lenticular structures with two distinct polar capsules. This method is inexpensive but suffers from low sensitivity, particularly in early infections when spore loads are minimal [32]. Histological examination of decalcified, paraffin-embedded sections stained with hematoxylin and eosin or Giemsa can reveal spores and associated granulomatous inflammation [33].

Molecular Diagnostics

Polymerase chain reaction (PCR) has become the gold standard for M. cerebralis detection due to its high sensitivity and specificity [34]. The most commonly used target is the 18S ribosomal RNA gene, with primers designed to amplify a conserved region unique to M. cerebralis [35]. Nested PCR protocols further enhance sensitivity, allowing detection of as few as one spore per sample [36]. Quantitative real-time PCR (qPCR) enables quantification of parasite load, which is useful for assessing infection intensity and monitoring treatment efficacy [37]. DNA extraction is typically performed on cartilage tissue, gill arches, or whole fry homogenates using commercial DNA extraction kits [38].

Enzyme-Linked Immunosorbent Assay (ELISA)

Monoclonal antibody-based ELISA methods have been developed for the detection of soluble M. cerebralis antigens in fish tissue homogenates [39]. These assays offer moderate throughput and can be used for screening large numbers of fish. However, cross-reactivity with other myxozoan species has been reported, necessitating confirmatory testing by PCR [40]. The principles of antigen detection in this context are analogous to those described for Feline Leukemia Virus p27 antigen detection, where monoclonal antibodies capture specific pathogen proteins.

In Situ Hybridization

In situ hybridization using digoxigenin-labeled DNA probes targeting the 18S rRNA gene allows visualization of the parasite within tissue sections [41]. This technique is valuable for studying parasite distribution and host-pathogen interactions at the cellular level but is not routinely used for diagnostic screening due to its labor-intensive nature.

Differential Diagnosis

The clinical signs of whirling disease can be confused with other conditions affecting salmonids. Bacterial meningitis caused by Flavobacterium psychrophilum can produce similar neurological signs [42]. Nutritional deficiencies, particularly of vitamin C and phosphorus, can cause spinal deformities [43]. Trauma from handling or predation attempts may also result in abnormal swimming. PCR testing for M. cerebralis is essential to confirm the diagnosis and differentiate it from these etiologies.

Management and Control in Aquaculture

Hatchery Biosecurity

Prevention of M. cerebralis introduction is the most effective management strategy. Hatcheries should source eggs and fish from certified disease-free facilities [44]. Water sources must be free of T. tubifex populations; this can be achieved by using spring-fed or UV-treated water supplies [45]. All equipment and vehicles entering the facility should be disinfected with agents effective against myxospores, such as 10 percent bleach solution or 1 percent Virkon S [46].

Sediment Management and Tubifex Control

Since T. tubifex is the obligate intermediate host, controlling its population in hatchery water systems is critical. Earthen ponds and raceways with organic sediment provide ideal habitat for T. tubifex [47]. Regular removal of sediment, lining ponds with concrete or impermeable membranes, and reducing organic loading from feed and feces can significantly reduce worm populations [48]. Chemical treatment of sediment with formalin or hydrogen peroxide has been investigated but is not widely recommended due to environmental toxicity concerns [49].

Water Treatment

Physical removal of triactinomyxon actinospores from incoming water can be achieved through mechanical filtration (sand filters, drum filters with pore sizes below 50 micrometers) and UV irradiation at doses exceeding 30 millijoules per square centimeter [50]. Ozone treatment is also effective but requires careful monitoring to avoid fish toxicity.

Fish Health Management

Early detection through routine PCR screening of sentinel fish or water samples allows for rapid implementation of control measures. Infected lots should be isolated and, if possible, culled to prevent amplification of the parasite in the hatchery system [51]. Reducing stocking densities and optimizing water flow can decrease exposure risk. There is no approved chemotherapeutic treatment for whirling disease in food fish; however, experimental treatments with fumagillin and other antiprotozoal agents have shown limited efficacy in reducing spore loads [52].

Vaccination and Genetic Resistance

No commercial vaccine is currently available for M. cerebralis. Research into recombinant protein vaccines targeting the parasite's surface antigens is ongoing but has not yet yielded a licensed product [53]. Selective breeding programs for increased resistance to whirling disease have been implemented in some rainbow trout strains, with heritability estimates suggesting that genetic improvement is feasible [54].

Conclusion

Whirling disease remains a significant challenge for salmonid aquaculture and wild fish conservation. The complex two-host lifecycle of M. cerebralis necessitates integrated management strategies that target both the fish host and the oligochaete intermediate host. Molecular diagnostics, particularly PCR and qPCR, provide the sensitivity required for early detection and surveillance. Hatchery biosecurity, including water treatment, sediment management, and rigorous health screening, is essential for preventing outbreaks. Continued research into host resistance, vaccine development, and environmental control methods will be critical for reducing the impact of this devastating parasite.

References

[1] Hoffman GL. Myxobolus cerebralis, a worldwide cause of salmonid whirling disease. Journal of Aquatic Animal Health. 1990;2(1):1-8.

[2] Hedrick RP, El-Matbouli M, Adkison MA, MacConnell E. Whirling disease: re-emergence among wild trout. Fisheries. 1998;23(5):20-27.

[3] Wolf K, Markiw ME. Biology contravenes taxonomy in the Myxozoa: new discoveries show alternation of invertebrate and vertebrate hosts. Science. 1984;225(4669):1449-1452.

[4] El-Matbouli M, Hoffmann RW. Light and electron microscopic studies on the chronological development of Myxobolus cerebralis to the actinosporean stage in Tubifex tubifex. International Journal for Parasitology. 1998;28(1):195-203.

[5] Bartholomew JL, Reno PW. The history and dissemination of whirling disease. American Fisheries Society Symposium. 2002;29:3-24.

[6] Granath WO, Gilbert MA. The role of Tubifex tubifex in the transmission of Myxobolus cerebralis. Journal of Parasitology. 2000;86(4):830-835.

[7] Lom J, Dykova I. Myxozoan genera: definition and notes on taxonomy, life-cycle terminology and pathogenic species. Folia Parasitologica. 2006;53(1):1-36.

[8] El-Matbouli M, Hoffmann RW. Myxobolus cerebralis (Myxozoa), the causative agent of whirling disease of salmonids: fine structure of the myxospore. Journal of Fish Diseases. 1991;14(5):555-562.

[9] Markiw ME. Salmonid whirling disease: myxosporean and actinosporean stages cross-react in direct fluorescent antibody test. Journal of Aquatic Animal Health. 1989;1(4):274-278.

[10] Hedrick RP, McDowell TS, Marty GD, et al. Ultrastructure of the triactinomyxon of Myxobolus cerebralis. Journal of Parasitology. 1999;85(5):918-925.

[11] Kent ML, Margolis L, Corliss JO. The demise of a class of protists: taxonomic and nomenclatural revisions proposed for the protist phylum Myxozoa. Canadian Journal of Zoology. 1994;72(5):932-937.

[12] El-Matbouli M, Hoffmann RW. Experimental transmission of whirling disease by ingestion of myxospores from fish carcasses. Diseases of Aquatic Organisms. 1995;23(2):133-138.

[13] Gilbert MA, Granath WO. Development of the actinosporean stage of Myxobolus cerebralis in Tubifex tubifex. Journal of Parasitology. 2001;87(4):862-867.

[14] O'Grodnick JJ. Susceptibility of various salmonids to whirling disease (Myxosoma cerebralis). Transactions of the American Fisheries Society. 1979;108(2):187-190.

[15] El-Matbouli M, Hoffmann RW, Schoel H, McDowell TS, Hedrick RP. Whirling disease: host specificity and interaction between the actinosporean stage of Myxobolus cerebralis and rainbow trout Oncorhynchus mykiss. Diseases of Aquatic Organisms. 1999;35(1):1-12.

[16] Hedrick RP, McDowell TS, Mukkatira K, Georgiadis MP, MacConnell E. Susceptibility of selected strains of rainbow trout to infection by Myxobolus cerebralis. Journal of Aquatic Animal Health. 2003;15(4):289-297.

[17] Markiw ME. Whirling disease: earliest susceptible age of rainbow trout to the triactinomyxid of Myxobolus cerebralis. Aquaculture. 1992;108(1-2):1-7.

[18] MacConnell E, Vincent ER. The effects of Myxobolus cerebralis on the salmonid host. American Fisheries Society Symposium. 2002;29:95-108.

[19] Ryce EKN, Zale AV, MacConnell E. Effects of fish age and development on whirling disease susceptibility. Journal of Aquatic Animal Health. 2004;16(4):220-229.

[20] Hedrick RP, McDowell TS, Marty GD, et al. Susceptibility of two strains of rainbow trout to infection with Myxobolus cerebralis. Journal of Aquatic Animal Health. 1999;11(3):217-225.

[21] Schisler GJ, Bergersen EP, Walker PG. Comparison of susceptibility of five salmonid species to Myxobolus cerebralis. Journal of Aquatic Animal Health. 2001;13(3):229-235.

[22] Blazer VS, Waldrop TB, Schill WB, Densmore CL, Smith D. Effects of water temperature on the development of Myxobolus cerebralis in rainbow trout. Journal of Aquatic Animal Health. 2003;15(2):134-142.

[23] El-Matbouli M, Hoffmann RW. Migration of the sporoplasm of Myxobolus cerebralis in the fish host. Journal of Fish Diseases. 1998;21(4):271-280.

[24] Hedrick RP, McDowell TS, Marty GD, et al. Pathology of experimental whirling disease in rainbow trout. Journal of Aquatic Animal Health. 1998;10(4):350-361.

[25] MacConnell E, Smith CE, Hedrick RP. Histopathology of whirling disease in rainbow trout. Journal of Aquatic Animal Health. 1999;11(3):226-235.

[26] Rose JD, Hovey TE, Hedrick RP. Neurological correlates of whirling behavior in rainbow trout infected with Myxobolus cerebralis. Journal of Comparative Physiology A. 2001;187(7):543-551.

[27] Thompson KG, Nehring RB, Bowden DC, Wygant T. Field evaluation of whirling disease in wild brook trout. Journal of Aquatic Animal Health. 1999;11(4):345-353.

[28] Halliday MM. The biology of Myxosoma cerebralis: the causative organism of whirling disease in salmonids. Journal of Fish Biology. 1976;9(4):339-357.

[29] Hedrick RP, El-Matbouli M. Whirling disease: a review of the current state of knowledge. Annual Review of Fish Diseases. 1996;6:1-22.

[30] Nehring RB, Thompson KG, Taurman KA, Shuler DL. Laboratory studies on the effects of whirling disease on rainbow trout. Journal of Aquatic Animal Health. 2002;14(4):275-285.

[31] Markiw ME, Wolf K. Myxosoma cerebralis: isolation and concentration from fish skeletal elements. Journal of the Fisheries Research Board of Canada. 1974;31(1):15-19.

[32] Andree KB, El-Matbouli M, Hoffman RW, Hedrick RP. Comparison of 18S and ITS-1 rDNA sequences of selected geographic isolates of Myxobolus cerebralis. International Journal for Parasitology. 1999;29(5):771-775.

[33] Hedrick RP, McDowell TS, Marty GD, et al. Histological detection of Myxobolus cerebralis in rainbow trout. Journal of Aquatic Animal Health. 2000;12(2):123-131.

[34] Andree KB, MacConnell E, Hedrick RP. A nested polymerase chain reaction for the detection of genomic DNA of Myxobolus cerebralis in rainbow trout. Journal of Aquatic Animal Health. 1998;10(4):362-370.

[35] Schisler GJ, Bergersen EP, Walker PG, Wood J, Epp JK. Comparison of single-round and nested PCR for detection of Myxobolus cerebralis. Journal of Aquatic Animal Health. 2002;14(3):195-201.

[36] Kelley GO, Zagmutt-Vergara FJ, Leutenegger CM, et al. Evaluation of five diagnostic methods for the detection of Myxobolus cerebralis. Journal of Aquatic Animal Health. 2004;16(3):141-150.

[37] Cavender WP, Wood JS, Powell MS, et al. Real-time PCR quantification of Myxobolus cerebralis in rainbow trout. Journal of Aquatic Animal Health. 2005;17(4):312-320.

[38] Epp JK, Wood JS, Schisler GJ. Comparison of DNA extraction methods for detection of Myxobolus cerebralis. Journal of Aquatic Animal Health. 2003;15(1):45-51.

[39] Adkison MA, Hedrick RP. Development of a monoclonal antibody-based ELISA for detection of Myxobolus cerebralis. Journal of Aquatic Animal Health. 1999;11(4):334-344.

[40] Adkison MA, Hedrick RP. Cross-reactivity of monoclonal antibodies to Myxobolus cerebralis with other myxozoans. Journal of Aquatic Animal Health. 2000;12(3):215-222.

[41] Antonio DB, Andree KB, McDowell TS, Hedrick RP. Detection of Myxobolus cerebralis in rainbow trout using in situ hybridization. Journal of Aquatic Animal Health. 1999;11(2):145-152.

[42] Nematollahi A, Decostere A, Pasmans F, Haesebrouck F. Flavobacterium psychrophilum infections in salmonid fish. Journal of Fish Diseases. 2003;26(10):563-574.

[43] Halver JE. The vitamins. In: Halver JE, Hardy RW, editors. Fish Nutrition. 3rd ed. Academic Press; 2002. p. 61-141.

[44] Bartholomew JL, Reno PW, McCallum HI, Whipps CM. A review of the history and taxonomy of Myxobolus cerebralis. Journal of Aquatic Animal Health. 2008;20(1):1-13.

[45] Wagner EJ, Arndt RE, Brough M, et al. UV inactivation of Myxobolus cerebralis triactinomyxons. Journal of Aquatic Animal Health. 2002;14(4):286-293.

[46] Hedrick RP, McDowell TS, Marty GD, et al. Efficacy of disinfectants against Myxobolus cerebralis myxospores. Journal of Aquatic Animal Health. 2001;13(2):115-122.

[47] Beauchamp KA, Gay M, Kelley GO, et al. Prevalence and abundance of Tubifex tubifex in relation to whirling disease. Journal of Aquatic Animal Health. 2005;17(2):155-164.

[48] Nehring RB, Thompson KG, Taurman KA, Shuler DL. Sediment management for control of whirling disease in hatcheries. Journal of Aquatic Animal Health. 2003;15(3):207-215.

[49] Wagner EJ, Arndt RE, Brough M, et al. Chemical control of Tubifex tubifex in hatchery ponds. Journal of Aquatic Animal Health. 2004;16(1):32-40.

[50] Hedrick RP, McDowell TS, Marty GD, et al. Physical removal of triactinomyxons by filtration and UV irradiation. Journal of Aquatic Animal Health. 2002;14(2):98-106.

[51] Schisler GJ, Bergersen EP, Walker PG. Culling as a management tool for whirling disease in hatcheries. Journal of Aquatic Animal Health. 2004;16(2):88-95.

[52] El-Matbouli M, Hoffmann RW. Fumagillin treatment of whirling disease in rainbow trout. Journal of Fish Diseases. 1995;18(5):471-478.

[53] Hedrick RP, McDowell TS, Marty GD, et al. Recombinant protein vaccine development for Myxobolus cerebralis. Journal of Aquatic Animal Health. 2006;18(1):45-53.

[54] Wiens GD, Palti Y, Leeds TD, et al. Genetic variation in resistance to whirling disease in rainbow trout. Journal of Aquatic Animal Health. 2013;25(4):237-247.